\
&
Contact us
\
&
Contact us
Published on | 9 months ago
Programmes Security CybersecurityThe Commission launched a call for expression of interest to join the new Industry-Academia Network under the European Cyber Skills Academy.
This network will strengthen the links between industry and academia to boost cybersecurity skills, ensuring the European cyber workforce is adequately equipped to meet growing demands in the sector.
Members of the network will include stakeholders of the Cybersecurity Skills Academy and higher education institutions, European University Alliances, and vocational education and training (VET) providers. They will focus on aligning the needs of the cybersecurity job market with academic and training offerings that suit current and emerging needs of the workforce. Concrete partnerships are expected to emerge, encompassing joint curricula, mentorship programmes, apprenticeships, and other initiatives.
The call will remain open on a permanent basis, however, stakeholders wishing to be part of the network's launch group should apply by 5 January 2025.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security Digital, Industry & Space AI Continent Cybersecurity
The European Commission has opened a call for evidence to collect research and best practices on how to simplify its legislation, especially when it comes to data, cybersecurity and artificial intelligence (AI). This initiative is part of the Commission’s simplification agenda and efforts to create a more favourable business environment, by... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
